Publications
- PALB2 as Another Candidate Gene for Genetic Testing in Patients with Hereditary Breast Cancer in Czech Republic2016 | First Faculty of Medicine
- Hereditary truncating mutations of DNA repair and other genes in BRCA1/BRCA2/PALB2-negatively tested breast cancer patients2016 | First Faculty of Medicine
- RE: frameshift variant FANCL*c.1096_1099dupATTA is not associated with high breast cancer risk2016 | First Faculty of Medicine
- Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic2016 | First Faculty of Medicine
- Mutation Analysis of the RAD51C and RAD51D Genes in High-Risk Ovarian Cancer Patients and Families from the Czech Republic2015 | First Faculty of Medicine
- Association of Germline CHEK2 Gene Variants with Risk and Prognosis of Non-Hodgkin Lymphoma2015 | First Faculty of Medicine
- Expression of human BRCA1 Delta 17-19 alternative splicing variant with a truncated BRCT domain in MCF-7 cells results in impaired assembly of DNA repair complexes and aberrant DNA damage response2013 | First Faculty of Medicine, Third Faculty of Medicine
- The PALB2 Gene Is a Strong Candidate for Clinical Testing in BRCA1- and BRCA2-Negative Hereditary Breast Cancer2013 | First Faculty of Medicine
- The BRCA1 alternative splicing variant Delta 14-15 with an in-frame deletion of part of the regulatory serine-containing domain (SCD) impairs the DNA repair capacity in MCF-7 cells2012 | First Faculty of Medicine, Third Faculty of Medicine
- Germline mutations 657del5 and 643C > T (R215W) in NBN are not likely to be associated with increased risk of breast cancer in Czech women2012 | First Faculty of Medicine
Loading network view...